Announcement of The Financial Report for The Third Quarter of 2020
2020.11.3
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 2 | Date of announcement | 2020/11/3 | Time of announcement | 17:27:16 |
| Subject | Announcement of The Financial Report for The Third Quarter of 2020 | ||||
| Date of events | 2020/11/3 | To which item it meets | paragraph 31 | ||
| Statement | 1.Date of the financial reports submitted to the board of directors or approved by the board of directors:2020/11/03 2.Date of the financial reports approved by the audit committee:Not applicable 3.Year/Quarter of financial reports:2020 Third Quarter 4.Accumulated operating revenue in the reporting period (thousand NTD):3,019,005 5.Accumulated gross profit (loss) from operations in the reporting period (thousand NTD):1,929,607 6.Accumulated net operating income (loss) in the reporting period (thousand NTD):713,886 7.Accumulated profit (loss) before tax in the reporting period (thousand NTD):870,679 8.Accumulated profit (loss) during the period attributable to owners of parent in the reporting period (thousand NTD):661,564 9.Accumulated basic earnings (loss) per share in the reporting period (NTD):2.66 10.Total assets end of the reporting period (thousand NTD):9,310,809 11.Total liabilities end of the reporting period (thousand NTD):3,519,309 12.Equity attributable to owners of parent end of the reporting period (thousand NTD):5,177,380 13.Any other matters that need to be specified:None |
||||